Global High-Priority Regulatory Events — September 14, 2026

14-09-2026

MiniMed Group, Inc. filed an S-4 registration statement in connection with its spin-off from Medtronic plc, which was completed on March 9, 2026. The filing provides comprehensive audited financial statements for fiscal years ended April 24, 2026, April 25, 2025, and April 26, 2024. Revenue grew 11.5% YoY to $3,089M in FY2026, driven by strong performance in Pumps (+12.7%) and Consumables (+13.0%), but Continuous Glucose Monitoring (CGM) systems revenue declined 2.1% YoY to $41.9M. Net income increased 14.5% to $349M, while operating income rose 13.0% to $477M.

• · The spin-off from Medtronic was completed on March 9, 2026, with MiniMed becoming an independent publicly traded company.
• · An IPO of common stock occurred on March 9, 2026, with proceeds used to fund the separation.
• · A $1.5B revolving credit facility was entered into on January 15, 2026.
• · A $50M charge was recorded in FY2026 for termination of a third-party manufacturing agreement.
• · The company is involved in a Diabetes Pump Retainer Ring Litigation, with lawsuits filed in California, Washington, and New York on April 1, 2026, and a subsequent event on June 17, 2026.
• · An international arbitration with EOFlow Co., Ltd. was initiated in June 2024.
• · Related-party transactions with Medtronic include allocated expenses, transition services, and amounts due to/from parent company.
• · U.S. revenue was $2,200M (71.2% of total) in FY2026, while non-U.S. revenue was $889M (28.8%).
• · Research and development expenses were $350M in FY2026, compared to $320M in FY2025 (9.4% increase).
• · Selling, general and administrative expenses were $1,200M in FY2026, compared to $1,080M in FY2025 (11.1% increase).

14-09-2026

Drugs Made In America Acquisition Corp. (DMAA), a SPAC, entered into an amended and restated definitive merger agreement with Power Analytics Global Corp (PAGC), a private AI and analytics company, dated September 8, 2026. The merger values PAGC at a Closing Valuation of US$2,850,000,000, with DMAA to domesticate as a Delaware corporation and PAGC surviving as a wholly-owned subsidiary. The agreement amends the original April 29, 2026 merger agreement, and the parties have abandoned a contingent amendment that would have added a second target with a combined equity value of US$3,000,000,000.

• · The merger is an affiliated business combination because PAGC and BV Advisory Partners, LLC (holding convertible notes and entitled to at least 40% of sponsor-level economics) are under common principal ownership.
• · The contingent amendment to add an additional target (APQC) with a combined equity value of US$3,000,000,000 has not become effective and becomes void if conditions are not satisfied by September 30, 2026; the parties do not intend to bring it into effect.
• · PAGC has entered into a Letter of Intent with APQC Inc and Santosh Kumar dated July 23, 2026, to acquire 100% of APQC, with the APQC Acquisition intended to be completed prior to Closing.
• · The Closing Valuation is subject to delivery of a Fairness Opinion, determinations by independent directors, and approval by DMAA's board.
• · The agreement includes a Debt-Free Condition requiring PAGC to be free of material indebtedness at Closing, other than Bridge Financing and ordinary trade payables.

14-09-2026

NorthStrive Acquisition Corp I. filed an 8-K on September 14, 2026, announcing the adoption of corporate governance policies and committee charters effective September 9, 2026, following its August 2026 IPO. The policies include a Code of Conduct and Ethics, Insider Trading Compliance Policy, and a Clawback Policy, along with charters for the Compensation, Nominating, and Audit Committees. No financial results or business combination updates were disclosed.

• · The policies were adopted on September 10, 2026, effective as of September 9, 2026.
• · The Clawback Policy complies with Nasdaq listing rules and Section 10D of the Exchange Act.
• · The related-party transaction threshold is set at $120,000 per calendar year.
• · The Audit Committee is responsible for investigating and enforcing the Code of Conduct and Ethics.

14-09-2026

Embrace Change Acquisition Corp. (EMCG) announced the termination of its merger agreement with Tianji Tire Global (Cayman) Limited, originally entered on January 26, 2025 and amended on October 16, 2025. Tianji delivered a termination notice on September 10, 2026, citing the failure to consummate the merger by the August 12, 2026 outside date. The termination was not due to any breach by EMCG, but the deal has been abandoned, leaving EMCG without a target business combination.

• · The Merger Agreement was originally signed on January 26, 2025 and amended on October 16, 2025.
• · The termination was effective as of September 10, 2026, per Section 11.1(d)(i) of the Merger Agreement.
• · The outside date for the merger was August 12, 2026.
• · The termination right was not available to a party if the failure to close was due to that party's breach; the filing does not indicate any breach by EMCG.

14-09-2026

CMI Ltd, under Corporate Insolvency Resolution Process (CIRP) since August 2023, has filed unaudited financial results for the quarter and half year ended 30th September 2025. The auditor, Kumar Pramod & Associates, has issued a disclaimer of opinion, citing that accumulated losses of Rs. 16,863.91 lakh have completely eroded the net worth of Rs. 1,603.07 lakh, and the company has been incurring continued losses for many years, raising significant going concern doubts. The financial statements are not prepared under Ind AS, and multiple records (fixed assets register, bank confirmations, inventory details) were unavailable for review.

• · The company has been under CIRP since August 2023, initiated by financial creditor Canara Bank under Section 7 of the IBC.
• · The financial statements are prepared under Rule 7 of the Companies (Accounts) Rules, 2014, not under Ind AS 34.
• · Contingent liabilities related to TDS disputes and GST matters could not be ascertained due to lack of details.
• · Fixed assets register, bank confirmations, inventory details, and reconciliations for trade receivables/payables were not available for review.
• · Pending litigations have not been independently verified by the auditor.

14-09-2026

MTNL has disclosed a default in payment of principal and interest to seven banks as of 31.08.2026, with total outstanding bank borrowings of Rs 9,654 crore and total financial indebtedness of Rs 37,475 crore. The default amounts have been overdue since between August 2024 and February 2025, indicating a prolonged and worsening liquidity situation.

• · Default dates range from 12-08-2024 (UBI) to 03-02-2025 (IOB), with all defaults overdue for over 18 months as of 31.08.2026.
• · The largest single default is with Indian Overseas Bank at Rs 2,735.35 crore (principal Rs 2,300.00 crore, interest Rs 435.35 crore).
• · Union Bank of India has the highest overdue principal at Rs 3,334.57 crore and overdue interest at Rs 878.49 crore.
• · Total financial indebtedness includes SG Bond of Rs 24,071 crore and a DoT loan of Rs 3,750 crore for SG Bond interest.
• · The disclosure is made under Regulation 30 of SEBI (LODR) Regulations, 2015 and SEBI Circular dated 21.11.2019.

14-09-2026

Texas Capital Bancshares voluntarily delists its common stock (TCBI) and preferred stock (TCBIO) from Nasdaq, effective October 7, 2026, and transfers listing to the Texas Stock Exchange (TXSE) starting October 8, 2026. The common stock initially retains its TCBI ticker, while the preferred stock trades under TCBI PRB; both will switch to TXCP and TXCP PRB on November 9, 2026. The move is a strategic listing change with no financial impact or performance data disclosed.

• · Delisting from Nasdaq effective market close October 7, 2026
• · TXSE listing begins market open October 8, 2026
• · Preferred stock ticker changes to TCBI PRB initially, then to TXCP PRB on November 9, 2026
• · Common stock ticker changes to TXCP on November 9, 2026
• · Board of Directors authorized the voluntary delisting and transfer

14-09-2026

Cambium Networks Corp's subsidiary CNL filed for administration in the UK High Court on September 14, 2026. The company simultaneously cut 260 employees (53.6% of workforce) effective September 11 without severance, including SVP Products Vibhu Vivek. The administrators will attempt to sell assets and business lines, but the company expects the remaining CNL group entities to be wound up.

• · The subsidiary CNL filed for administration under the Insolvency Act 1986 and Insolvency (England and Wales) Rules 2016.
• · The filing was made in the High Court of Justice Business and Property Courts of England and Wales.
• · No severance payments were offered or made to the 260 terminated employees.
• · Costs associated with the restructuring could not be estimated at the time of filing.
• · The company's ordinary shares trade under the symbol CMBMF (N/A exchange).

14-09-2026

Future Vision II Acquisition Corp. (FVNNR) entered into a $65,000 unsecured promissory note with HWei Super Speed Co. Ltd. to extend the deadline for its initial business combination by one month, from September 13, 2026 to October 13, 2026. The note is non-interest bearing and must be deposited into the trust account, with the principal due upon consummation of a business combination or at liquidation. The payee has the option to convert the principal into units at $10.00 per unit upon a business combination, but if no deal occurs and the SPAC liquidates, the note is forgiven, and the payee waives all claims against the trust account.

• · The note is unsecured and non-interest bearing.
• · Conversion option: up to $1.5M aggregate principal of extension loans can be converted into units at $10.00 per unit.
• · If no business combination occurs and the SPAC liquidates, the note is forgiven and the payee waives all rights to the trust account.
• · Note may not be assigned or transferred prior to business combination without Maker's written consent.
• · Events of default include failure to pay within 5 business days or voluntary bankruptcy.
• · Governing law: New York.

14-09-2026

Standard Capital Markets Ltd. announced that the NCLT Ahmedabad Bench approved its resolution plan for Bhagirath Construction Company Private Limited under Section 31 of the IBC, effective 09 September 2026. The approval marks a milestone in the company's resolution and investment activities, and implementation will proceed per the plan and NCLT directions.

• · NCLT order pronounced on 09 September 2026 in IA(Plan) No. 13 of 2026 in CP(IB) No. 294/(AHM)/2023
• · Resolution plan approved under Section 31 of the Insolvency and Bankruptcy Code, 2016
• · Company acted as Successful Resolution Applicant (SRA) for the Corporate Insolvency Resolution Process (CIRP)
• · Approval received from the Resolution Professional of the Corporate Debtor
• · Disclosure made under Regulation 30 of SEBI LODR Regulations

14-09-2026

Teva Pharmaceutical Industries Ltd has filed a Form 25-NSE with the SEC to delist its American Depositary Shares (ADS) from the New York Stock Exchange, effective September 25, 2026. The delisting follows the completion of a mandatory exchange of each ADS for one ordinary share on September 14, 2026, as part of the termination of the ADS program. This action does not affect the continued listing of Teva's ordinary shares on the NYSE.

• · The delisting affects only the American Depositary Shares (CUSIP: 881624209).
• · Ordinary shares (CUSIP: M8769Q102) remain listed on the NYSE.
• · Trading of the ADS was suspended on September 14, 2026.
• · The mandatory exchange was completed on September 14, 2026, with each ADS exchanged for one ordinary share.
• · The delisting becomes effective at the opening of business on September 25, 2026.

14-09-2026

Yatra Online, Inc. filed an amended solicitation/recommendation statement (SC 14D9/A) in response to an unsolicited partial tender offer by Magna Holdings Ltd. to purchase up to 20,000,000 ordinary shares (approximately 31% of outstanding shares) at $1.10 per share in cash. The offer, originally set to expire September 25, 2026, was extended by Magna, which also eliminated the minimum tender condition of 15,997,545 shares. The Board's recommendation and detailed response to the offer remain unchanged from the prior filing.

• · The offer is scheduled to expire at 12:00 midnight (one minute after 11:59 p.m.), New York City time, on September 25, 2026, unless extended or earlier terminated.
• · If more than 20,000,000 shares are validly tendered, the Offeror will purchase shares on a pro rata basis, subject to adjustment to avoid fractional shares.
• · The Offeror reserves the right to purchase more than 20,000,000 shares in its sole discretion, subject to certain limitations.
• · The Offeror eliminated the condition that a minimum of 15,997,545 shares (approximately 25% of outstanding) be validly tendered.
• · The Offer is subject to numerous conditions including Material Adverse Effect, No Litigation, No Legal Restraint, and No External Events conditions.
• · The Offeror stated it does not currently intend to further extend the Offer, but if it does, it will announce by 9:00 a.m. New York City time on the next business day after the previously scheduled expiration.

14-09-2026

BlackRock Private Investments Fund completed its tender offer to repurchase up to 5% of its outstanding common shares. The offer was undersubscribed, with only 214,338.799 Institutional Shares tendered and repurchased; no Class D, S, or T shares were tendered. The total repurchase cost was approximately $3,221,512.14, paid via promissory notes to shareholders.

• · Offer expired on May 29, 2026, at 11:59 p.m. Eastern time.
• · Valuation date for repurchased shares was June 30, 2026.
• · NAV per Institutional Share on Valuation Date: $15.03.
• · NAV per Class D Share on Valuation Date: $14.83.
• · No Class S or Class T shares were outstanding on the Valuation Date.
• · Only Institutional shares were tendered; all were accepted for repurchase.

14-09-2026

Magnolia Oil & Gas Corporation (MGY) completed its acquisition of WildFire Energy on September 10, 2026. The deal was previously announced and has now closed, expanding Magnolia's operations in the Eagle Ford Shale and Austin Chalk formations. No financial terms or performance metrics were disclosed in this filing.

• · Acquisition was previously announced and has now closed.
• · Operations are concentrated in South Texas in the core of the Eagle Ford Shale and Austin Chalk formations.
• · Company strategy focuses on moderate annual production growth, high pre-tax operating margins, consistent free cash flow, and strong cash returns to shareholders.

14-09-2026

Quince Therapeutics completed the sale of its Italian subsidiary and related assets (including the eDSP/EryDex technology and AIDE systems) to Ayma Therapeutics for $450,000 in cash, with a preliminary pro forma gain on sale of $1.749 million. The transaction eliminates the Italian subsidiary's operating losses, reducing pro forma net loss for the six months ended June 30, 2026 from $41.071 million to $52.447 million (a 28% increase in net loss), reflecting transaction costs and tax impacts. The company also effected 1-for-10 and 1-for-20 reverse stock splits in April 2026, which are reflected in the pro forma figures.

• · The sale transaction closed on September 8, 2026.
• · The company effected a 1-for-10 reverse stock split effective April 10, 2026, and a 1-for-20 reverse stock split (dates not specified).
• · Pro forma adjustments include elimination of Quince SPA's operating results, derecognition of assets and liabilities, and recognition of transaction costs and tax impacts.
• · The pro forma gain on sale is preliminary and could change materially as additional information is obtained.
• · The company elected not to present Management's Adjustments under Article 11 of Regulation S-X.
• · The pro forma financial information is for illustrative purposes only and does not purport to represent actual results.

14-09-2026

Hudson Acquisition I Corp. (HUDA) held a Special Meeting on September 14, 2026, where all seven proposals related to the business combination with EUROEV Holdings Limited (Aiways) were unanimously approved (2,072,493 FOR, 0 AGAINST, 0 ABSTAIN on most items), with 98.17% of outstanding shares represented. However, the redemption of shares by a small group of stockholders—6,140 shares redeemed for approximately $67,725 at $11.03 per share—reduced the trust account to only about $246,300, signaling limited cash runway and potential liquidity risk post-combination.

• · The redemption left only ~$246,300 in the trust account, which may be insufficient for post-closing operations without additional financing.
• · A total of 2,072,493 votes (100% of those voted) supported each proposal, with zero votes AGAINST on 6 of 7 proposals; only one abstention on proposal 5 (Equity Incentive Plan).
• · The equity plan allows up to 5 million shares initially, with annual increases of up to 750,000 shares through 2035.
• · Proposal 6 releases up to 3 million restricted shares held by insiders.

14-09-2026

Z Squared Inc. (Nasdaq: ZSQR) announced the closing of its acquisition of Paradox Data, LLC, acquiring the energized Union County Campus in El Dorado, Arkansas, as its first owned AI-ready colocation site. The campus currently has 8.0 MW of interruptible power from Entergy Arkansas, with a development target of 150+ MW through phased conversion and adjacent land acquisition; the acquisition was completed entirely in stock with no cash or debt. While the company achieved its first goal of closing the deal, the expanded capacity remains a development target with no signed customer commitments yet, and the company must still secure power arrangements, financing, and permits.

• · The campus electric service is interruptible (not guaranteed) under the Entergy Arkansas arrangement.
• · Expansion beyond 8.0 MW depends on additional power arrangements, customer commitments, financing, permitting, and construction.
• · The company intends to acquire additional sites without taking on debt, but this is subject to discipline and not guaranteed.
• · Z Squared's common stock began trading on Nasdaq under symbol 'ZSQR' in April 2026.

14-09-2026

Nasdaq Stock Market LLC filed a Form 25-NSE with the SEC on September 14, 2026, to delist Comcast Corp's 'Notes due 2026' (ticker CCZ) under 17 CFR 240.12d2-2(a)(2). The delisting is effective upon filing, and the company's common stock remains listed on Nasdaq.

• · The delisting is for the specific security 'Notes due 2026' (CCZ), not for Comcast's common stock.
• · The filing cites SEC Rule 17 CFR 240.12d2-2(a)(2) as the basis for delisting.
• · The filing was made by Nasdaq, not by Comcast itself.

14-09-2026

byNordic Acquisition Corporation (BYNO) deposited $8,850.20 into its trust account to extend the deadline to complete a business combination by one month, from September 12, 2026 to October 12, 2026. This is the second of up to twelve monthly extensions available under an amendment to its charter, allowing extensions through August 12, 2027. The company, led by CEO Michael Hermansson, continues to search for a target, focusing on high-tech growth companies in northern Europe.

• · The extension is the second of up to twelve one-month extensions permitted under the August 7, 2026 amendment to the Company's Amended and Restated Certificate of Incorporation.
• · The board of directors may elect to extend the termination date by one additional month each time up until August 12, 2027, or the closing of the Company's initial business combination.
• · The Company intends to focus its search on high technology growth companies based in the northern part of Europe.

14-09-2026

Ondas Holdings Inc. acquired GATE Technologies, an Israeli developer of electronic safe-and-arm devices and advanced fuzing technologies, along with its European affiliate Bron Technologies. The total consideration is $205 million, mostly payable in cash, plus up to $185 million in performance-based earn-out consideration. The acquisition is expected to contribute more than $130 million in aggregate Adjusted EBITDA through 2028, but the company faces risks related to integration, forward-looking projections, and the need to establish U.S. production capabilities by the first half of 2027.

• · GATE products are integrated into more than dozens of weapon systems, including rockets, missiles, UAVs and loitering munitions.
• · The acquisition adds Israeli engineering and NATO-based, non-ITAR production, certification and distribution through Bron Technologies in Poland.
• · U.S.-produced finished products and integrated systems are targeted for the first half of 2027.
• · The fact sheet includes forward-looking statements and cautions that actual results could differ materially due to risks discussed in Ondas' SEC filings.

14-09-2026

Air Lease Corporation (AL) filed an S-4 registration statement on September 14, 2026, in connection with an exchange offer to register up to $4.0 billion aggregate principal amount of exchange notes (2028, 2029, 2031, and 2036 series). The exchange offer is being made to satisfy registration rights obligations following the company's merger on April 8, 2026, which resulted in the company becoming an indirect subsidiary of Sumisho Air Lease Corporation Designated Activity Company, jointly owned by Sumitomo Corporation, SMBC Aviation Capital, Apollo, and Brookfield. The filing incorporates by reference the company's 2025 10-K, Q1 10-Q, and Q2 10-Q, and includes extensive risk factors related to the company's significant indebtedness, aircraft investment returns, and competitive environment.

• · The exchange offer is not conditioned upon any minimum principal amount of outstanding notes being tendered.
• · Tendering must be done through DTC's Automated Tender Offer Program (ATOP).
• · The exchange notes are substantially identical to the outstanding notes except that transfer restrictions, restrictive legends, registration rights, and Additional Interest provisions will not apply.
• · The company's fleet utilization rate was 99.5% for the six months ended June 30, 2026.
• · The company's fleet had a weighted average age of 4.8 years and a weighted average remaining lease term of 7.0 years as of June 30, 2026.
• · The Merger was completed on April 8, 2026, and the company's Class A Common Stock was delisted from the NYSE effective April 18, 2026.
• · The company no longer has an OEM orderbook after the Merger, which may impact its ability to manage its aircraft portfolio.

14-09-2026

Medtronic plc has filed a Schedule TO with the SEC to launch an exchange offer, proposing to swap up to 225,361,295 newly issued shares of MiniMed Group, Inc. common stock (representing approximately 80.1% of MiniMed's outstanding shares) for outstanding Medtronic ordinary shares. The exchange offer is an issuer tender offer under Rule 13e-4, and if oversubscribed, Medtronic may exchange an additional 27,452,053 MiniMed shares (its remaining interest) for up to 2% of outstanding Medtronic ordinary shares. Medtronic ordinary shares accepted in the offer will be redeemed and cancelled, and the company's directors do not intend to tender their shares.

• · Medtronic directors do not intend to tender their shares in the exchange offer.
• · Medtronic ordinary shares accepted will be redeemed and cancelled.
• · The exchange offer is open to all holders of Medtronic ordinary shares, including officers and affiliates, on the same terms.
• · MiniMed has filed a Form S-4 registration statement (No. 333-298914) with the SEC for the new MiniMed shares.
• · Medtronic's fiscal 2027 first quarter (ended July 31, 2026) stock price range: high $88.98, low $73.31.
• · Medtronic's fiscal 2027 second quarter (through September 11, 2026) stock price range: high $95.41, low $84.95.
• · Several executive officers exercised stock options and paid tax liabilities via share withholding in late July and August 2026, at prices between $85.39 and $92.30 per share.

14-09-2026

Shell plc's guarantor of its 2.500% Guaranteed Notes due 2026 was removed from listing and registration on the NYSE, effective September 25, 2026, after the notes were redeemed at maturity on September 12, 2026. Trading of the security was suspended on September 14, 2026. This is a routine debt maturity event and does not reflect any operational or financial distress for Shell plc.

• · The delisting is pursuant to 17 CFR 240.12d2-2(a)(2) for redemption at maturity.
• · The security was suspended from trading on September 14, 2026.
• · The removal from listing becomes effective at the opening of business on September 25, 2026.

14-09-2026

The New York Stock Exchange notified the SEC that the entire class of Shell International Finance B.V.'s 2.500% Guaranteed Notes due 2026 will be removed from listing and registration, effective at the opening of business on September 25, 2026. The securities were redeemed or paid at maturity on September 12, 2026, and trading was suspended on September 14, 2026. This is a routine delisting following the notes' maturity, with no financial impact or negative implications.

• · The delisting is pursuant to Rule 12d2-2(a)(2) under the Securities Exchange Act of 1934.
• · The securities were redeemed or paid at maturity on September 12, 2026.
• · Trading was suspended on September 14, 2026.
• · The removal from listing and registration is effective at the opening of business on September 25, 2026.

14-09-2026

Banco Santander, S.A. is delisting its Series 114 1.722% Senior Non Preferred Callable Fixed-to-Fixed Rate Notes due 2027 from the New York Stock Exchange, effective September 25, 2026. The delisting follows the redemption, maturity, or retirement of the entire class of these securities on September 14, 2026, with sufficient funds deposited and made available to holders. Trading in the notes was suspended on the same date.

• · The delisting is effective at the opening of business on September 25, 2026.
• · The security was suspended from trading on September 14, 2026.
• · The delisting is pursuant to Rule 12d2-2(a)(1) under the Securities Exchange Act of 1934.
• · Funds sufficient for payment were deposited with an authorized agency and made available to security holders on September 14, 2026.

14-09-2026

SmartKem, Inc. regained compliance with Nasdaq's minimum bid price rule after its closing bid price remained at or above $1.00 per share for 13 consecutive business days (August 21 through September 9, 2026). Nasdaq notified the company on September 10, 2026, that the matter is closed, resolving the prior delisting risk.

• · The company had previously received a formal notice on March 5, 2026, of non-compliance with the Minimum Bid Price Rule.
• · The compliance period ran from August 21 through September 9, 2026.
• · The Staff notified the company on September 10, 2026, that it had regained compliance and deemed the matter closed.

14-09-2026

83 Investment Group Income Fund has commenced a tender offer to repurchase up to 5% of its net assets (approximately $14.56M based on July 31, 2026 NAV of $291.18M) from shareholders. The offer began September 14, 2026, with a Notice Date of October 13, 2026, and an Acceptance Date of November 12, 2026. Shareholders may tender shares by midnight Eastern time on the Notice Date, and the purchase price will be based on the net asset value as of the Valuation Date (December 31, 2026). The Fund reserves the right to cancel, amend, or postpone the offer, and shareholders can withdraw tenders until the Expiration Date.

• · The Fund is a closed-end, non-diversified management investment company registered under the Investment Company Act of 1940.
• · The offer expires on November 12, 2026, unless extended; shareholders can withdraw tenders until midnight Eastern time on the Expiration Date.
• · The purchase price will be based on the net asset value as of the Valuation Date (December 31, 2026), which may differ from the Prior NAV Calculation Date (July 31, 2026).
• · The Fund reserves the right to repurchase all of a shareholder's shares if the aggregate value is below a certain threshold at the time of tender.
• · Shareholders can obtain the most current estimated NAV by calling (833) 701-4393.

14-09-2026

Barclays PLC is delisting two series of senior notes (6.496% Fixed-to-Floating Rate Senior Callable Notes due 2027 and Floating Rate Senior Callable Notes due 2027) from the New York Stock Exchange effective September 25, 2026, following a redemption call on September 13, 2026. The securities were suspended from trading on September 14, 2026, and sufficient funds for payment were deposited and made available to holders on the same date. This is a routine debt retirement event and does not reflect any operational or financial distress for Barclays.

• · The delisting is pursuant to Rule 12d2-2(a)(1) under the Securities Exchange Act of 1934.
• · The securities were called for redemption/maturity on September 13, 2026.
• · Funds sufficient for payment were deposited with an authorized agency and made available to holders on September 14, 2026.
• · Trading was suspended on September 14, 2026.
• · The delisting becomes effective at the opening of business on September 25, 2026.

14-09-2026

Veracyte, Inc. (VCYT) acquired Convergent Genomics for $150M upfront cash plus up to $30M in milestone payments, adding the UroAmp urinary tumor DNA testing platform to its urology diagnostics portfolio. The acquisition strengthens Veracyte's bladder cancer offerings across urine, tissue, and blood, with an initial UroAmp test expected to commercialize in late 2028. However, Veracyte is not updating its previously provided 2026 adjusted EBITDA guidance, and the deal's financial impact remains uncertain in the near term.

• · Convergent Genomics was founded in 2015 and operates a CLIA-CMS certified lab in South San Francisco.
• · UroAmp has been clinically validated in NMIBC for therapy-response monitoring and post-treatment surveillance.
• · The RUMBLE study showed utDNA-positive patients had only 25% 12-month recurrence-free survival vs. 91% for utDNA-negative patients.
• · Veracyte's initial UroAmp test will target patients who have completed BCG induction therapy to assess benefit from maintenance treatment.
• · Veracyte is not updating its 2026 adjusted EBITDA guidance to reflect the acquisition's operating expenses.